Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases [Phase 2]
A Phase 2 clinical trial evaluating the optimal combination of radiotherapy and immunotherapy to induce the abscopal effect in patients with…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
An observational clinical study evaluating stereotactic radiotherapy for advanced non-small cell lung cancer in patients with stable disease…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 [Phase 1]
Phase 1 clinical trial evaluating XMT-2056 in HER2-expressing advanced or recurrent solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Personalized DC Vaccines in Non Small Cell Lung Cancer [Phase 1]
Phase 1 trial update on a personalized dendritic cell vaccine for non-small cell lung cancer; the study status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC [Phase 2]
A Phase 2 trial evaluating radiation therapy followed by tislelizumab and anlotinib as adjuvant or neoadjuvant therapy for Stage II-IIIA non…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT [Phase 2]
Phase 2 clinical trial evaluating radiotherapy plus anlotinib for locally advanced non-small cell lung cancer intolerant to concurrent chemo…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
This clinical trial is evaluating multiple omics sequencing technologies to predict treatment efficacy in non-small cell lung cancer and to …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.
A study evaluating atezolizumab in PD-L1 high advanced non-small cell lung cancer with correlative c-FLIP analysis in monocytic myeloid-deri…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan
A clinical trial in Japan is evaluating the effectiveness and safety of first-line nivolumab plus ipilimumab, with or without chemotherapy, …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
A clinical trial update examining tumor-associated neutrophils as a biomarker of chemo-immunotherapy response in locally advanced non-small …
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
This clinical trial update discusses using geriatric assessment to guide treatment decisions for elderly patients with locally advanced non-…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC [Phase 2]
A Phase 2 clinical trial evaluating JS207 in combination with chemotherapy as first-line treatment for advanced non-small cell lung cancer, …
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Metabolic Response to Food in Lung Cancer
This clinical trial investigates how metabolic response to food occurs in Non-Small Cell Lung Cancer. The study is currently active but not …
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy [NA]
A City of Hope Medical Center-led clinical trial is evaluating geriatric assessment and management for older adults with non-small cell lung…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors [Phase 1]
This Phase 1 clinical trial from AbbVie tests ABBV-637 alone or in combination with intravenous docetaxel or osimertinib in adults with rela…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
This clinical trial is evaluating extracellular vesicles and particles as biomarkers of recurrence in non-small cell lung cancer and is curr…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of infusions of iNKT cells and CD8+ T cells in patients with advanced solid tu…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation [Phase 1]
Phase Ib clinical trial update for JMKX001899 in combination with other therapies for advanced non-small cell lung cancer harboring KRAS G12…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Primary Resistance Mechanisms of ALK TKIs
This clinical trial entry outlines a study to investigate primary resistance mechanisms to ALK inhibitors in patients with ALK-positive adva…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC [Phase 2]
A Phase II, single-arm study evaluating tislelizumab in combination with anlotinib and platinum-based chemotherapy as perioperative therapy …
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer
A registered clinical trial sponsored by Fudan University investigates the risk and prognosis of brain metastases in patients with non-small…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study [NA]
A clinical trial update for the STARLighT study testing exercise and nutrition as interventions for outcomes in early-stage non-small cell l…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) [Phase 3]
This is a status update for a Phase 3 confirmatory trial in non-small cell lung cancer patients with MET exon 14 mutation, currently recruit…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer
A clinical trial is investigating oral metronomic vinorelbine in combination with PD-1 inhibitors for elderly patients with non-small cell l…